OM
DRNA

Opaleye Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Opaleye Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-134,500
Closed -$1.71M – 39
2014
Q3 		$1.71M Buy
+134,500
New +$2.03M 1.33% 23

Other funds holding DRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management's DRNA Position: Q4 2014 in Review

Opaleye Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2014, closing a stake of 134,500 shares — an estimated $1.71M sold.

Opaleye Management first reported a position in DRNA in Q3 2014 and held it in 1 quarter. The position peaked at $1.71M in Q3 2014. 47 funds tracked by Wall St. Rank hold DRNA as of Q4 2014.

  • Opaleye Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Opaleye Management sold 134,500 Dicerna Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1.71M.
  • Opaleye Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
  • Opaleye Management's Dicerna Pharmaceuticals, Inc. position peaked at $1.71M in Q3 2014.
  • 47 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2014.

Based on Opaleye Management's 13F filing for Q4 2014, filed 13 Feb 2015.